The WHO has held a closed expert meeting to identify potential vaccines for the Bundibugyo species of Ebola that is causing ...
UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category with $21 billion ...
Fresh from agreeing a wide-ranging alliance with Regeneron worth up to $2.3 billion, Parabilis Medicines has decided to ...
Neuroscience isn't currently one of the top strategic R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting. The UK-headquartered pharma group is ...
An analysis by pharma trade body EFPIA has found "widening equality" in the access to new medicines across 36 European countries that could be compounded by the introduction of the Most Favoured ...
A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Ramy Younes, corporate vice president, global head of ...
A phase 2 trial of Sanofi's experimental therapy for alpha-1 antitrypsin deficiency (AATD) has raised the hope of an ...
The US Supreme Court has rejected lawsuits from pharma groups challenging Medicare's drug pricing negotiation powers, saying ...
The White House has confirmed that the trade deal signed with the EU – which includes an overarching tariff rate of 15% on imports into the US – does extend to most pharmaceutical products. The only ...
The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...
Novartis has reported new data to support its drive to expand the label of its radioligand therapy Pluvicto to include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results